← FDA Drug Approvals (Drugs@FDA)
MOVIPREP
NDA · New Drug Application · Sponsor: SALIX PHARMS · Approved 2006-08-02
Drug application
- FDA Application #
NDA021881- Application type
- New Drug Application
- Brand name
- MOVIPREP
- Generic name
- POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE
- Active ingredients
- ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
- Dosage form
- FOR SOLUTION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SALIX PHARMS
- Manufacturer
- Salix Pharmaceuticals, Inc.
- First approval
- 2006-08-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown